S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among ethiopians

被引:78
|
作者
Persson, I
Aklillu, E
Rodrigues, F
Bertilsson, L
IngelmanSundberg, M
机构
[1] KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,S-17177 STOCKHOLM,SWEDEN
[2] UNIV ADDIS ABABA,FAC MED,ADDIS ABABA,ETHIOPIA
[3] HUDDINGE UNIV HOSP,KAROLINSKA INST,DIV CLIN PHARMACOL,DEPT MED LAB SCI & TECHNOL,S-14186 HUDDINGE,SWEDEN
来源
PHARMACOGENETICS | 1996年 / 6卷 / 06期
关键词
cytochrome P450; mephenytoin; omeprazole; proguanil; genotype; genetic polymorphism;
D O I
10.1097/00008571-199612000-00005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The polymorphic metabolism of S-mephenytoin and the distribution of two known deleterious mutant CYP2C19 alleles was determined among 114 healthy unrelated black Ethiopians, Six subjects (5.2%) were poor metabolizers (PMs) of S-mephenytoin, The frequencies of the defective CYP2C19*2 (CYP2C19m1) and CYP2C19+3 (CYP2C19m2) alleles were 0.14 and 0.02, respectively, Three of the PMs were homozygous for the CYP2C19*2 allele and the remaining three PMs were heterozygous for both the CYP2C192 and CYP2C19*3 mutant alleles, It is concluded that the frequency of PMs for S-mephenytoin is similar in Ethiopians, Zimbabweans and Caucasians and that the CYP2C19*3 allele, for the first time identified in a black population, together with the CYP2C19*2 allele account for all of the defective CYP2C19 alleles among the Ethiopan PMs.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 50 条
  • [21] CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population
    JurimaRomet, M
    Goldstein, JA
    LeBelle, M
    Aubin, RA
    Foster, BC
    Walop, W
    Rode, A
    PHARMACOGENETICS, 1996, 6 (04): : 329 - 339
  • [22] A new genetic defect in human CYP2C19:: Mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin
    Ferguson, RJ
    De Morais, SMF
    Benhamou, S
    Bouchardy, C
    Blaisdell, J
    Ibeanu, G
    Wilkinson, GR
    Sarich, TC
    Wright, JM
    Dayer, P
    Goldstein, JA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (01): : 356 - 361
  • [23] Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4′-hydroxylation phenotype and genotype
    Tanaka, M
    Ohkubo, T
    Otani, K
    Suzuki, A
    Kaneko, S
    Sugawara, K
    Ryokawa, Y
    Hakusui, H
    Yamamori, S
    Ishizaki, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) : 619 - 628
  • [24] Characterization of CYP2C19 and CYP2C9 from human liver:: Respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations
    Lasker, JM
    Wester, MR
    Aramsombatdee, E
    Raucy, JL
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 353 (01) : 16 - 28
  • [25] Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity
    Klaassen, Tobias
    Jetter, Alexander
    Tomalik-Scharte, Dorota
    Kasel, Dirk
    Kirchheiner, Julia
    Jaehde, Ulrich
    Fuhr, Uwe
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (04) : 387 - 398
  • [26] Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity
    Tobias Klaassen
    Alexander Jetter
    Dorota Tomalik-Scharte
    Dirk Kasel
    Julia Kirchheiner
    Ulrich Jaehde
    Uwe Fuhr
    European Journal of Clinical Pharmacology, 2008, 64 : 387 - 398
  • [27] Individual difference in drug metabolism and disposition:: Toxicological significance of genotypes and phenotypes of S-mephenytoin 4′-hydroxylase (CYP2C19)
    Ikebuchi, J
    Yamada, M
    Ogura, Y
    Yamamoto, Y
    Nishimura, A
    Nishi, K
    Yamada, K
    Irizawa, Y
    PROGRESS IN FORENSIC GENETICS 9, 2003, 1239 : 589 - 592
  • [28] Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype
    Helsby, Nuala A.
    Lo, Wing-Yee
    Simpson, Ian J.
    Voss, David M.
    Logan, Kaye E.
    Searle, Martin
    Schollum, John B. W.
    de Zoysa, Janak R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 516 - 519
  • [29] The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians
    Rosemary, J
    Adithan, C
    Padmaja, N
    Shashindran, CH
    Gerard, N
    Krishnamoorthy, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (01) : 19 - 23
  • [30] The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians
    J Rosemary
    C Adithan
    N Padmaja
    C H Shashindran
    N Gerard
    R Krishnamoorthy
    European Journal of Clinical Pharmacology, 2005, 61 : 19 - 23